Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells.

[1]  V. Khedkar,et al.  Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives. , 2012, Bioorganic & medicinal chemistry letters.

[2]  N. Sahu,et al.  Exploring pharmacological significance of chalcone scaffold: a review. , 2012, Current medicinal chemistry.

[3]  Keduo Qian,et al.  Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation. , 2011, Bioorganic & medicinal chemistry.

[4]  Lorenzo Caggiano,et al.  Design, synthesis and antiproliferative activity of urocanic-chalcone hybrid derivatives , 2011 .

[5]  Y. Na,et al.  Chalcones as Novel Non-peptidic μ-Calpain Inhibitors , 2011 .

[6]  Young Min Kim,et al.  Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition. , 2011, Bioorganic & medicinal chemistry letters.

[7]  W. Maltese,et al.  A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells , 2011, Molecular Cancer.

[8]  Y. Asiri,et al.  Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study. , 2011, Bioorganic & medicinal chemistry.

[9]  Xue-Quan Wang,et al.  Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole. , 2011, Organic and biomolecular chemistry.

[10]  P. Paré,et al.  Estrogenic activity of chemical constituents from Tephrosia candida. , 2011, Journal of natural products.

[11]  S. Riyadh.  Enaminones as Building Blocks for the Synthesis of Substituted Pyrazoles with Antitumor and Antimicrobial Activities , 2011, Molecules.

[12]  R. Roden,et al.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells. , 2011, Journal of medicinal chemistry.

[13]  W. Oh,et al.  Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. , 2011, Bioorganic & medicinal chemistry letters.

[14]  N. Suh,et al.  Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth. , 2010, Bioorganic & medicinal chemistry letters.

[15]  S. Dulchavsky,et al.  Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. , 2010, Anticancer research.

[16]  P. Reddanna,et al.  Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors. , 2010, Bioorganic & medicinal chemistry.

[17]  R. F. Hartman,et al.  Cell Cycle Arrest and Apoptosis Induction by an Anticancer Chalcone Epoxide , 2010, Archiv der Pharmazie.

[18]  B. Insuasty,et al.  Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. , 2010, Bioorganic & medicinal chemistry.

[19]  Peng-Cheng Lv,et al.  Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. , 2010, Bioorganic & medicinal chemistry.

[20]  J. Heilmann,et al.  Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. , 2010, European journal of medicinal chemistry.

[21]  So Ha Lee,et al.  Design and synthesis of new potent anticancer pyrazoles with high FLT3 kinase inhibitory selectivity. , 2010, Bioorganic & medicinal chemistry.

[22]  C. Khobragade,et al.  Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. , 2009, Bioorganic & medicinal chemistry.

[23]  Y. Tzeng,et al.  Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation. , 2009, Bioorganic & medicinal chemistry.

[24]  B. Srinivasan,et al.  Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. , 2009, Journal of medicinal chemistry.

[25]  F. Souard,et al.  A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models , 2009, BMC Cancer.

[26]  D. Hadjipavlou-Litina,et al.  Chalcones in cancer: understanding their role in terms of QSAR. , 2009, Current medicinal chemistry.

[27]  Shinji Ohta,et al.  C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. , 2008, Journal of natural products.

[28]  B. Wasylyk,et al.  Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules. , 2008, Cancer research.

[29]  J. Gut,et al.  Antimalarial prenylated chalcones from the twigs of Dorstenia barteri var. subtriangularis , 2007 .

[30]  G. Pauli,et al.  The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[31]  B. Ngadjui,et al.  Antitrichomonal and antioxidant activities of Dorstenia barteri and Dorstenia convexa. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[32]  X. Wu,et al.  Chalcones: an update on cytotoxic and chemoprotective properties. , 2005, Current medicinal chemistry.

[33]  G. Folefoc,et al.  Diprenylated chalcones and other constituents from the twigs of Dorstenia barteri var. subtriangularis. , 2004, Phytochemistry.

[34]  F. Gozzo,et al.  Regioselectivity in aromatic Claisen rearrangements. , 2003, The Journal of organic chemistry.

[35]  R. Tapia,et al.  Synthesis and antiprotozoal activity of naphthofuranquinones and naphthothiophenequinones containing a fused thiazole ring. , 2003, Bioorganic & medicinal chemistry.

[36]  F. Belluti,et al.  Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid. , 2002, Journal of medicinal chemistry.

[37]  C. Di Giorgio,et al.  1,3-Diphenylpyrazoles: synthesis and antiparasitic activities of azomethine derivatives. , 2002, European journal of medicinal chemistry.

[38]  J. Roseiro,et al.  Flavonoids from Ulex airensis and Ulex europaeus ssp. europaeus. , 2002, Journal of natural products.

[39]  S. Kouam,et al.  Prenylated flavonoids from the aerial parts of Dorstenia mannii. , 2000, Phytochemistry.

[40]  W. Ryan,et al.  Automated parallel synthesis of chalcone-based screening libraries , 1998 .

[41]  T. Maduskuie,et al.  Hydroxyacetophenone-derived antagonists of the peptidoleukotrienes. , 1989, Journal of Medicinal Chemistry.

[42]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.